The KRAS gene exhibits a high mutation rate among all cancers [20], and is particularly associated with 78.7% of pancreatic adenocarcinoma (PAAD), 20.1% of lung adenocarcinoma (LUAD), and 49.7% of colorectal adenocarcinoma (COAD) [21]. The gene discussed is KRAS; the disease is pancreatic adenocarcinoma.